|Mr. Nicholas T. Curtis||CEO & Director||748.46k||N/A||1956|
|Mr. Thomas R. Staab II||Chief Financial Officer||347.26k||N/A||1968|
|Mr. Alan B. Connaughton||Chief Operating Officer||519.52k||N/A||1972|
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. The company was incorporated in 2004 and is headquartered in Orlando, Florida.
LENSAR, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.